MEDICAL SHIELDS China’s pharmaceutical companies gear up to develop drugs and vaccines for COVID-19 treatment  

作　　者：Yuan Yuan 

机构地区：[1]不详

出　　处：《Beijing Review》2020年第19期16-17,共2页北京周报（英文版）

摘　　要：A drug approved for Chinese market last year as an antibiotic was unexpectedly found to be quite effective in treating patients with the novel coronavirus disease(COVID-19).Known as Carrimycin,it was independently developed by Chinese researchers over a lengthy period of 30 years.Developed for upper respiratory infections。

关 键 词：MARKET DRUG novel 

分 类 号：R563.1[医药卫生—呼吸系统] F426.72[医药卫生—内科学]